{
    "paper_id": "a6f083f9abd608db6cb2fbf83f3609e384456c16",
    "metadata": {
        "title": "APOE E4 GENOTYPE PREDICTS SEVERE COVID-19 IN THE UK BIOBANK COMMUNITY COHORT",
        "authors": [
            {
                "first": "Chia-Ling",
                "middle": [],
                "last": "Kuo",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "University of Connecticut Farmington",
                    "location": {
                        "region": "CT",
                        "country": "USA"
                    }
                },
                "email": ""
            },
            {
                "first": "Luke",
                "middle": [
                    "C"
                ],
                "last": "Pilling",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "University of Connecticut Farmington",
                    "location": {
                        "region": "CT",
                        "country": "USA"
                    }
                },
                "email": ""
            },
            {
                "first": "Janice",
                "middle": [
                    "L"
                ],
                "last": "Atkins",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "University of Exeter Medical School",
                    "location": {
                        "settlement": "Exeter",
                        "country": "UK"
                    }
                },
                "email": ""
            },
            {
                "first": "Jane",
                "middle": [
                    "Ah"
                ],
                "last": "Masoli",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "University of Exeter Medical School",
                    "location": {
                        "settlement": "Exeter",
                        "country": "UK"
                    }
                },
                "email": ""
            },
            {
                "first": "Jo\u00e3o",
                "middle": [],
                "last": "Delgado",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "University of Exeter Medical School",
                    "location": {
                        "settlement": "Exeter",
                        "country": "UK"
                    }
                },
                "email": ""
            },
            {
                "first": "George",
                "middle": [
                    "A"
                ],
                "last": "Kuchel",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "University of Connecticut Farmington",
                    "location": {
                        "region": "CT",
                        "country": "USA"
                    }
                },
                "email": ""
            },
            {
                "first": "David",
                "middle": [
                    "Melzer"
                ],
                "last": "Mbbch",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "University of Connecticut Farmington",
                    "location": {
                        "region": "CT",
                        "country": "USA"
                    }
                },
                "email": ""
            }
        ]
    },
    "abstract": [],
    "body_text": [
        {
            "text": "The novel respiratory disease COVID-19 produces varying symptoms, with fever, cough, and shortness of breath being common. In older adults, we found that pre-existing dementia is a major risk factor (OR = 3.07, 95% CI: 1.71 to 5.50) for COVID-19 hospitalization in the UK Biobank (UKB) [1] . In another UK study of 16,749 patients hospitalized for COVID-19 [2] , dementia was among the common comorbidities and was associated with higher mortality.",
            "cite_spans": [
                {
                    "start": 286,
                    "end": 289,
                    "text": "[1]",
                    "ref_id": "BIBREF0"
                },
                {
                    "start": 357,
                    "end": 360,
                    "text": "[2]",
                    "ref_id": "BIBREF1"
                }
            ],
            "ref_spans": [],
            "section": ""
        },
        {
            "text": "Additionally, impaired consciousness, including delirium, is common in severe cases [3] . The ApoE e4 genotype is associated with both dementia and delirium [4] , with the e4e4 (homozygous) genotype associated with high risk of dementia. We therefore aimed to test associations between ApoE e4 alleles and COVID-19 severity, using the UKB data.",
            "cite_spans": [
                {
                    "start": 84,
                    "end": 87,
                    "text": "[3]",
                    "ref_id": "BIBREF2"
                },
                {
                    "start": 157,
                    "end": 160,
                    "text": "[4]",
                    "ref_id": "BIBREF3"
                }
            ],
            "ref_spans": [],
            "section": ""
        },
        {
            "text": "UKB is a community cohort currently aged 48 to 86 [5] . COVID-19 laboratory test results for UKB participants in England are available from March 16 to April 26, 2020, the peak period of COVID-19 incidence in the current outbreak [6] . Because testing for older adults during the above period was essentially restricted to hospital in-patients with clinical signs of infection, test positivity is a marker of severe COVID-19 [7] .",
            "cite_spans": [
                {
                    "start": 50,
                    "end": 53,
                    "text": "[5]",
                    "ref_id": "BIBREF4"
                },
                {
                    "start": 230,
                    "end": 233,
                    "text": "[6]",
                    "ref_id": "BIBREF5"
                },
                {
                    "start": 425,
                    "end": 428,
                    "text": "[7]",
                    "ref_id": "BIBREF6"
                }
            ],
            "ref_spans": [],
            "section": ""
        },
        {
            "text": "We analyzed UKB data from genetically European ancestry participants [8] A logistic regression model was used to compare e3e4 or e4e4 genotypes to e3e3 for COVID-19 positivity status, adjusted for: sex; age at the COVID-19 test or age on 26 th April, . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.",
            "cite_spans": [
                {
                    "start": 69,
                    "end": 72,
                    "text": "[8]",
                    "ref_id": "BIBREF7"
                }
            ],
            "ref_spans": [],
            "section": ""
        },
        {
            "text": "The copyright holder for this preprint this version posted May 11, 2020. As ApoE e4e4 prevalence is higher in people of African descent, we analyzed data for UKB self-reported Black participants: e4e4 was present in 5.2% of Blacks versus 2.3% of Whites.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "(which was not certified by peer review)"
        },
        {
            "text": "Blacks were more likely to get severe COVID-19 than Whites (e4e4 OR= 3.96, 95% CI: 2.92 to 5.35), which reduced to 3.80 (95% CI: 2.81 to 5.15) after ApoE adjustment (e4e4 p = 6.34\u00d710 -6 ), additional to sex, age at test, genotyping array type, and assessment center.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "(which was not certified by peer review)"
        },
        {
            "text": "In conclusion, ApoE e4 allele increases risks of being hospitalized with COVID-19, independent of pre-existing dementia, cardiovascular disease, and type-2 diabetes. ApoE not only affects lipoprotein function (and subsequent cardio-metabolic diseases) but also moderates macrophage pro-/anti-inflammatory phenotypes [9] . The novel coronavirus SARS-. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.",
            "cite_spans": [
                {
                    "start": 316,
                    "end": 319,
                    "text": "[9]",
                    "ref_id": "BIBREF8"
                }
            ],
            "ref_spans": [],
            "section": "(which was not certified by peer review)"
        },
        {
            "text": "The copyright holder for this preprint this version posted May 11, 2020. . https://doi.org/10.1101/2020.05.07.20094409 doi: medRxiv preprint CoV-2 causing COVID-19 uses the ACE2 receptor for cell entry. ACE2 is highly expressed in type II alveolar cells in the lungs, where ApoE is one of highly co-expressed genes [10] .",
            "cite_spans": [
                {
                    "start": 315,
                    "end": 319,
                    "text": "[10]",
                    "ref_id": "BIBREF9"
                }
            ],
            "ref_spans": [],
            "section": "(which was not certified by peer review)"
        },
        {
            "text": "ApoE e4 allele frequency is higher in people of African ancestry than in Europeans, and preliminary results suggest that ApoE e4 prevalence makes a modest contribution to the excess incidence of COVID-19 in Blacks. Further investigation is needed to understand biological mechanisms linking ApoE genotypes to COVID-19 severity.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "(which was not certified by peer review)"
        },
        {
            "text": ". CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "(which was not certified by peer review)"
        },
        {
            "text": "The copyright holder for this preprint this version posted May 11, 2020. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)",
            "cite_spans": [],
            "ref_spans": [],
            "section": "(which was not certified by peer review)"
        },
        {
            "text": "The copyright holder for this preprint this version posted May 11, 2020. . https://doi.org/10.1101/2020.05.07.20094409 doi: medRxiv preprint",
            "cite_spans": [],
            "ref_spans": [],
            "section": "(which was not certified by peer review)"
        }
    ],
    "bib_entries": {
        "BIBREF0": {
            "ref_id": "b0",
            "title": "Preexisting comorbidities predicting severe COVID-19 in older adults in the UK Biobank community cohort",
            "authors": [
                {
                    "first": "J",
                    "middle": [
                        "L"
                    ],
                    "last": "Atkins",
                    "suffix": ""
                },
                {
                    "first": "Jah",
                    "middle": [],
                    "last": "Masoli",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Delgado",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [
                        "C"
                    ],
                    "last": "Pilling",
                    "suffix": ""
                },
                {
                    "first": "C-L",
                    "middle": [],
                    "last": "Kuo",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [
                        "A"
                    ],
                    "last": "Kuchel",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Melzer",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Submiss",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF1": {
            "ref_id": "b1",
            "title": "Features of 16,749 hospitalised UK patients with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol. medRxiv",
            "authors": [
                {
                    "first": "A",
                    "middle": [
                        "B"
                    ],
                    "last": "Docherty",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [
                        "M"
                    ],
                    "last": "Harrison",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "A"
                    ],
                    "last": "Green",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [
                        "E"
                    ],
                    "last": "Hardwick",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Pius",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Norman",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [
                        "A"
                    ],
                    "last": "Holden",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "M"
                    ],
                    "last": "Read",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Dondelinger",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Carson",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Merson",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Lee",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Plotkin",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF2": {
            "ref_id": "b2",
            "title": "Neurological Manifestations of Hospitalized Patients with COVID-19 in Wuhan, China: A Retrospective Case Series Study",
            "authors": [
                {
                    "first": "L",
                    "middle": [],
                    "last": "Mao",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Chen",
                    "suffix": ""
                },
                {
                    "first": "Q",
                    "middle": [],
                    "last": "He",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Chang",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Hong",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Zhou",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "Miao",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Hu",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Li",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Jin",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Hu",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "JAMA Neurol",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF3": {
            "ref_id": "b3",
            "title": "ApoE e2 and aging-related outcomes in 379,000 UK Biobank participants. medRxiv",
            "authors": [
                {
                    "first": "C-L",
                    "middle": [],
                    "last": "Kuo",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [
                        "C"
                    ],
                    "last": "Pilling",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "L"
                    ],
                    "last": "Atkins",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [
                        "A"
                    ],
                    "last": "Kuchel",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Melzer",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF4": {
            "ref_id": "b4",
            "title": "The UK Biobank resource with deep phenotyping and genomic data",
            "authors": [
                {
                    "first": "C",
                    "middle": [],
                    "last": "Bycroft",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Freeman",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Petkova",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Band",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [
                        "T"
                    ],
                    "last": "Elliott",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Sharp",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Motyer",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Vukcevic",
                    "suffix": ""
                },
                {
                    "first": "O",
                    "middle": [],
                    "last": "Delaneau",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "O&apos;connell",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Cortes",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Welsh",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Young",
                    "suffix": ""
                }
            ],
            "year": 2018,
            "venue": "Nature",
            "volume": "562",
            "issn": "",
            "pages": "203--212",
            "other_ids": {}
        },
        "BIBREF5": {
            "ref_id": "b5",
            "title": "COVID-19) in the UK",
            "authors": [
                {
                    "first": "",
                    "middle": [
                        "Uk"
                    ],
                    "last": "Gov",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "Coronavirus",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF6": {
            "ref_id": "b6",
            "title": "COVID-19): Using data to track the virus",
            "authors": [
                {
                    "first": "",
                    "middle": [
                        "Uk"
                    ],
                    "last": "Gov",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "Coronavirus",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF7": {
            "ref_id": "b7",
            "title": "Common conditions associated with hereditary haemochromatosis genetic variants: Cohort study in UK Biobank",
            "authors": [
                {
                    "first": "L",
                    "middle": [
                        "C"
                    ],
                    "last": "Pilling",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Tamosauskaite",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Jones",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "R"
                    ],
                    "last": "Wood",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Jones",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "L"
                    ],
                    "last": "Kuo",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [
                        "A"
                    ],
                    "last": "Kuchel",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Ferrucci",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Melzer",
                    "suffix": ""
                }
            ],
            "year": 2019,
            "venue": "BMJ",
            "volume": "364",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF8": {
            "ref_id": "b8",
            "title": "Apolipoprotein E -A Multifunctional Protein with Implications in Various Pathologies as a Result of Its Structural Features",
            "authors": [
                {
                    "first": "I",
                    "middle": [
                        "F"
                    ],
                    "last": "Tudorache",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [
                        "G"
                    ],
                    "last": "Trusca",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "V"
                    ],
                    "last": "Gafencu",
                    "suffix": ""
                }
            ],
            "year": 2017,
            "venue": "Computational and Structural Biotechnology Journal",
            "volume": "",
            "issn": "",
            "pages": "359--65",
            "other_ids": {}
        },
        "BIBREF9": {
            "ref_id": "b9",
            "title": "Single-cell RNA expression profiling of ACE2, the putative receptor of Wuhan 2019-nCov. bioRxiv",
            "authors": [
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Zhao",
                    "suffix": ""
                },
                {
                    "first": "Z",
                    "middle": [],
                    "last": "Zhao",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Zhou",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Ma",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Zuo",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        }
    },
    "ref_entries": {
        "TABREF0": {
            "text": "(n=451,367, 90% of sample) attending baseline assessment centers in England (n=398,073), excluding participants who died before the epidemic (n=15,885). Single nucleotide polymorphism (SNP) data for rs429358 and rs7412 was used to determine ApoE genotypes: ApoE e4e4",
            "latex": null,
            "type": "table"
        },
        "TABREF1": {
            "text": "2020 (the last test date); baseline UKB assessment center in England; genotyping array type; and the top five genetic principal components (accounting for possible population admixture).ApoE e4e4 homozygotes were more likely to be COVID-19 test positives (Odds Ratio = 2.31, 95% Confidence Interval: 1.65 to 3.24, p= 1.19\u00d710 -6 ) compared to e3e3 homozygotes (Table 1). The association was similar after removing participants with ApoE e4 associated diseases that were also linked to COVID-19 severity: participants without dementia (OR= 2.39, 95% CI: 1.71 to 3.35); hypertension (OR= 2.41, 95% CI: 1.56 to 3.74); coronary artery disease (myocardial infarction or angina) (OR= 2.43, 95% CI: 1.69 to 3.50) or type 2 diabetes (OR= 2.51, 95% CI: 1.77 to 3.55) (Table 1), based on pre-existing diagnoses from baseline selfreports or hospital discharge statistics (updated to March 2017). The estimates were little changed using 136,146 participants with additional general practice data (up to 2017): participants without dementia (OR= 2.53, 95% CI: 1.46 to 4.39); hypertension (OR= 2.67, 95% CI: 1.34 to 5.32); coronary artery disease (OR= 2.86, 95% CI: 1.65 to 4.98) or type 2 diabetes (OR= 2.73, 95% CI: 1.57 to 4.76). The results were also similar after excluding 51,430 participants related to the 3 rd -degree or closer (OR= 2.34, 95% CI: 1.62 to 3.38).",
            "latex": null,
            "type": "table"
        },
        "TABREF3": {
            "text": "Risk of COVID-19 severity comparing participants with e3e4 or e4e4 genotypes to participants with e3e3 genotypes in UK Biobank* adjusted for sex, age at the COVID-19 test or age on 26 th April, 2020 (the last test date), assessment center in England, genotyping array type, and the top five genetic principal components",
            "latex": null,
            "type": "table"
        }
    },
    "back_matter": [
        {
            "text": ". CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "annex"
        },
        {
            "text": "The copyright holder for this preprint this version posted May 11, 2020. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "(which was not certified by peer review)"
        },
        {
            "text": "The copyright holder for this preprint this version posted May 11, 2020. . https://doi.org/10.1101/2020.05.07.20094409 doi: medRxiv preprint",
            "cite_spans": [],
            "ref_spans": [],
            "section": "(which was not certified by peer review)"
        }
    ]
}